# FDA Inspection 1302630 - Suresh Anne, M.D. - February 13, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/suresh-anne-md/702db3e3-c90d-4154-a9af-af832180260c
Source feed: FDA_Inspections

> FDA Inspection 1302630 for Suresh Anne, M.D. on February 13, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302630
- Company Name: Suresh Anne, M.D.
- Inspection Date: 2026-02-13
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: Detroit District Office

## Related Documents

- [FDA Inspection 1205635 - 2023-05-19](https://www.globalkeysolutions.net/records/fda_inspections/suresh-anne-md/0e93834a-f706-4113-b82c-e9796d856b90)

Company: https://www.globalkeysolutions.net/companies/suresh-anne-md/224b7a49-5956-463a-85ec-097c5b1d8fac

Office: https://www.globalkeysolutions.net/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03